Mainz Biomed B.V. (MYNZ) has released an update.
Mainz Biomed B.V. enters into a supplemental agreement with YA II PN, LTD., involving a third Pre-Paid Advance of $3.3 million, under the existing terms of their June 2023 Pre-Paid Advance Agreement. This financing move, which includes a modified fixed price convertible promissory note, aims to bolster Mainz Biomed’s working capital and support general corporate purposes. The deal underscores the company’s ongoing efforts to secure funding and strengthen its financial position for future growth.
For further insights into MYNZ stock, check out TipRanks’ Stock Analysis page.
